Molecular Basis of Intracellular Cholesterol Homeostasis
Molecular Basis of Intracellular Cholesterol Homeostasis
批准号:
12557095
负责人:
YOKOYAMA Shiniji
金额:
$8.32万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001
中文摘要
在本研究期间,载脂蛋白-细胞相互作用组装HDL的机制和生理相关性的研究成果总结如下。在小鼠体内再现了HDL降低药物普罗布考对HDL组装反应的抑制,并证明该反应是血浆HDL的主要来源(BBA 1485:199,2000),并且该反应的主要器官是肝脏(ATVB 21,394,2001)。小鼠单核细胞白血病细胞RAW 264中HDL的组装由cAMP诱导,与载脂蛋白与细胞的物理结合平行,并且abca 1 mRNA增加10托姆(Biochemistry 39,11092,2000)。从THP-1细胞和成纤维细胞的实验中发现,ABCA 1不是HDL组装的绝对必需品,小窝蛋白-1在胆固醇掺入HDL中起重要作用,孕酮通过未知的机制抑制该途径(JLR 41,1952,2000 ; JBC 277,7929,2002 ; BBA 1532,173,2001)。膜筏被认为是HDL组装的场所(JLR 41,894,2000)。当ABCA 1被转染并在HEK 293中功能性表达时,显示该蛋白质具有切割的信号肽和暴露于外部的N-末端(BBRC 283,1019,2001)。上述结果的一部分总结在一篇综述文章(BBA 1529,231,2000)中。
英文摘要
During the current grant term, research accomplishment is summarized below for the mechanism and physiological relevance of HDL assembly by apolipoprotein-cell interaction. Inhibition of the HDL assembly reaction by an HDL-lowering drug probucol was reproduced in mice in vivo, and demonstrated the this reaction is a main source of plasma HDL (BBA 1485 : 199, 2000) and the main organ for the reaction is the liver (ATVB 21, 394, 2001). Assembly of HDL in mouse monocytic leukemia cell RAW 264 is induced by cAMP in parallel with physical binding of apolipoprotein to the cell, and with 10-tome increase of abca1 mRNA (Biochemistry 39, 11092, 2000). From the experiments with THP-1 cells and fibroblasts, it was revealed that ABCA1 is not absolute requirement for the HDL assembly, that caveolin-1 plays an important role in incorporation of cholesterol into the HDL, and that progesterone inhibits this pathway by an unknown mechanism (JLR 41, 1952, 2000 ; JBC277, 7929, 2002 ; BBA 1532, 173, 2001). Membrane raft was suggested to be a site for the HDL assembly (JLR41, 894, 2000). When ABCA1 is transfected and functionally expressed in HEK293, the protein was shown with a signal peptide cleaved and the N-terminal exposed to outside (BBRC 283, 1019, 2001). A part of the results above is summarized in a review article (BBA 1529, 231, 2000).
期刊论文(98)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Shinji Yokoyama: "Release of cellular cholesterol: Molecular mechanism for cholesterol homeostasis in cells and in the body"Biochim. Biophys. Acta. 1529. 231-244 (2000)
横山真司:“细胞胆固醇的释放:细胞和体内胆固醇稳态的分子机制”Biochim。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Akitomo Goto, Kanna Sasai, Shogo Suzuki, Tatsuya Fukutomi, Shigenori Ito, Toyoaki Matsushita, Mitsuhiro Okamoto, Takahiko Suzuki, Makoto Itoh, Kuniko Okuyama-Noji, and Shinji Yokoyama: "Cholesteryl ester transfer protein and atherosclerosis in Japanese su
Akitomo Goto、Kanna Sasai、Shogo Suzuki、Tatsuya Fukutomi、Shigenori Ito、Toyoaki Matsushita、Mitsuhiro Okamoto、Takahiko Suzuki、Makoto Itoh、Kuniko Okuyama-Noji 和 Shinji Yokoyama:“日本人中的胆固醇酯转移蛋白和动脉粥样硬化
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Jin-ichi Ito, et al.: "Apolipoprotein A-I induces translocation of cholesterol, phospholipid and caveolin-1 to cvtosol in rat astrocytes"J. Biol. Chem.. 277. 7929-7935 (2002)
Jin-ichi Ito 等人:“载脂蛋白 A-I 诱导大鼠星形胶质细胞中胆固醇、磷脂和 Caveolin-1 易位至 cvtosol”。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Akitomo Goto, et al: "Cholesteryl ester transfer protein and atherosclerosis in Japanese subjects : A study based on coronary angiography."Atheroscelrosis. (in press). (2001)
Akitomo Goto 等人:“日本受试者中的胆固醇酯转移蛋白和动脉粥样硬化:基于冠状动脉造影的研究。”动脉粥样硬化。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 41 条
国内基金
海外基金
磷脂转运蛋白通过磷酸鞘氨醇1影响高密度脂蛋白抗动脉粥样硬化功能的分子机制
-
批准号:81070247
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2010
-
负责人:秦树存
-
依托单位:
脂蛋白脂肪酶对老年认知障碍的影响机制与生物学意义
-
批准号:30973145
-
项目类别:面上项目
-
资助金额:39.0万元
-
批准年份:2009
-
负责人:崔德华
-
依托单位:
细菌脂蛋白(BLP)诱导LPS交叉耐受的分子机理研究
-
批准号:30471791
-
项目类别:面上项目
-
资助金额:20.0万元
-
批准年份:2004
-
负责人:肖南
-
依托单位: